TREM2 and Alzheimer disease: TREM2 exemplifies context-dependent therapeutic duality: early inhibition reduces neuroinflammation in pre-plaque AD, whereas late-stage agonists increase fibrillar Aβ compaction and microglial clustering to improve cognition [30,117].